The general public is being warned by the FDA of the presence of a counterfeit version of Altuzan Bevacizumab by Roche; it was found to be without any active ingredient present. Background of Altuzan (bevacizumab) Altuzan (Bevacizumab) is a IV cancer drug for injection and it has a presence in the United States, although it [...]
Read more
The FDA has urged dermatologists, consumers, emergency medical professionals and the general public of the potential risks with skin lighteners and products marketed as anti-aging aids. In the safety warning, concerned parties have been alerted of the potential of there being either mercury or other toxic metal components in the ingredients of such products. Background [...]
Read more
A safety alert on the combination of Statins, Hepatitis C and HIV drugs has been brought to the attention of medical practitioners in infectious diseases, family practice, as well as patients at large. Medical professionals are hereby being updated of the changes in prescription details when administering combinations of protease inhibitors for either HCV or [...]
Read more
The FDA has alerted the general public of the recall for RegenErect in a move that was initiated by Regeneca Inc. which was previously known as Ethos Environmental Inc. RegenErect was recalled following findings of an unconfirmed drug component in the ingredients of the sexual performance-enhancing drug. Background of RegenErect RegenErect, a product of Regeneca [...]
Read more
Recent Comments